Physician profile
Patrick Akin
NPI 1073072096
$746.43
in general payments reported to CMS, 2019-2025
13 companies · $576 in 2025
The $576 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $30.12 · 2024: $140 · 2025: $576.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $746.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $746.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fidia Pharma USA INC. | $167.43 | 2025 | Triluron |
| Collegium Pharmaceutical, INC. | $112.91 | 2024-2025 | Belbuca |
| Scilex Pharmaceuticals INC. | $77.95 | 2024-2025 | |
| Boston Scientific Corporation | $71.21 | 2025 | General - Pain Management |
| Vertex Pharmaceuticals Incorporated | $54.05 | 2024-2025 | |
| Tonix Medicines, INC. | $52.88 | 2025 | Tonmya |
| Merz Pharmaceuticals, LLC | $47.00 | 2025 | Xeomin |
| Abbvie INC. | $46.88 | 2024-2025 | |
| Pfizer INC. | $30.39 | 2024 | |
| Bioventus LLC | $30.12 | 2023 | Exogen Ultrasound Bone Healing System |
| Saluda Medical Americas, INC. | $27.33 | 2025 | Evoke |
| Electronic Waveform Lab, INC. | $15.10 | 2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.18 | 2024 | Relistor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Akin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.